BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 04:32 pm

Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Thursday, 01st October, 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September, 2026.

Anuh Pharma Ltd · 506260

✦ AI Summary

Anuh Pharma Ltd has announced the closure of its trading window for insiders and designated persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anuh Pharma Ltd - 506260 - Closure of Trading Window

Attachments (1)

📄

3baad6ed-7c9d-4cfd-a08e-86ddb1109a85.pdf

pdf

Download →
View document text
Date: 28th September, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400001 Bandra (E), Mumbai - 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Intimation of closure of Trading Window Dear Sir, We would like to inform you that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with BSE Circular No. LIST/COMP/01/2019-20 dated 02nd April, 2019, the Trading window for dealing in the securities of Anuh Pharma Limited shall remain closed for all the insiders/designated persons and their immediate relatives, from Thursday, October 01, 2026 till the expiry of 48 hours after the declaration of Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2026. Accordingly, all the insiders/designated persons and their immediate relatives, as per the Company’s Code of Conduct for Prevention of Insider Trading, are advised not to deal in the securities of the Company during the aforementioned period of Closure of Trading Window. You are requested to kindly take the same on record. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Place: Mumbai